{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T11:04:26Z","timestamp":1760267066035,"version":"3.44.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"European Myastaid Project","award":["LSHM-CT-2006-037833"],"award-info":[{"award-number":["LSHM-CT-2006-037833"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1016\/j.jneuroim.2010.10.024","type":"journal-article","created":{"date-parts":[[2010,12,19]],"date-time":"2010-12-19T04:06:29Z","timestamp":1292731589000},"page":"158-165","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Reduced thymic expression of ErbB receptors without auto-antibodies against synaptic ErbB in myasthenia gravis"],"prefix":"10.1016","volume":"232","author":[{"given":"Kathleen","family":"Vrolix","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erik H.","family":"Niks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rozen","family":"Le Panse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monique M.","family":"van Ostaijen-ten Dam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne-Hilde","family":"Muris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cornelia M.","family":"Jol-van der Zijde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maarten J.D.","family":"van Tol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario","family":"Losen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter C.","family":"Molenaar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Everardus J.J.","family":"van Zoelen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonia","family":"Berrih-Aknin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc H.","family":"De Baets","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan J.G.M.","family":"Verschuuren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pilar","family":"Mart\u00ednez-Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2010.10.024_bb0005","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1073\/pnas.72.4.1456","article-title":"Immunological relationship between acetylcholine receptor and thymus: a possible significance in myasthenia gravis","volume":"72","author":"Aharonov","year":"1975","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jneuroim.2010.10.024_bb0010","first-page":"78","article-title":"Phase II study of weekly intravenous trastuzumab (Herceptin) in patients with HER2\/neu-overexpressing metastatic breast cancer","volume":"26","author":"Baselga","year":"1999","journal-title":"Semin Oncol"},{"key":"10.1016\/j.jneuroim.2010.10.024_bb0015","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0959-4388(00)00210-5","article-title":"Neuregulin and ErbB receptor signaling pathways in the nervous system","volume":"11","author":"Buonanno","year":"2001","journal-title":"Curr Opin Neurobiol"},{"key":"10.1016\/j.jneuroim.2010.10.024_bb0020","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1212\/01.WNL.0000085865.55513.AE","article-title":"Rapsyn mutations in hereditary myasthenia: distinct early- and late-onset phenotypes","volume":"61","author":"Burke","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2010.10.024_bb0025","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1002\/mus.20854","article-title":"Frequency of seronegativity in adult-acquired generalized myasthenia gravis","volume":"36","author":"Chan","year":"2007","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jneuroim.2010.10.024_bb0030","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jneuroim.2008.06.028","article-title":"Thymus and Myasthenia Gravis: what can we learn from DNA microarrays?","volume":"201-202","author":"Cizeron-Clairac","year":"2008","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.jneuroim.2010.10.024_bb0035","doi-asserted-by":"crossref","first-page":"2639","DOI":"10.1200\/JCO.1999.17.9.2639","article-title":"Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease","volume":"17","author":"Cobleigh","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jneuroim.2010.10.024_bb0040","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.1172\/JCI29894","article-title":"Myasthenia gravis: past, present, and future","volume":"116","author":"Conti-Fine","year":"2006","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jneuroim.2010.10.024_bb0045","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1056\/NEJM199406233302507","article-title":"Myasthenia gravis","volume":"330","author":"Drachman","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jneuroim.2010.10.024_bb0050","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/j.1749-6632.1976.tb47676.x","article-title":"The motor end plate in myasthenia gravis and in experimental autoimmune myasthenia gravis. A quantitative ultrastructural study","volume":"274","author":"Engel","year":"1976","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.jneuroim.2010.10.024_bb0055","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1212\/WNL.27.4.307","article-title":"Ultrastructural localization of the acetylcholine receptor in myasthenia gravis and in its experimental autoimmune model","volume":"27","author":"Engel","year":"1977","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2010.10.024_bb0060","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1093\/brain\/awg223","article-title":"Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis","volume":"126","author":"Evoli","year":"2003","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2010.10.024_bb0065","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1038\/nature06066","article-title":"An IRF8-binding promoter variant and AIRE control CHRNA1 promiscuous expression in thymus","volume":"448","author":"Giraud","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.jneuroim.2010.10.024_bb0070","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1212\/WNL.55.1.7","article-title":"Practice parameter: thymectomy for autoimmune myasthenia gravis (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology","volume":"55","author":"Gronseth","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2010.10.024_bb0075","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1172\/JCI1248","article-title":"Regulation of acetylcholine receptor gene expression in human myasthenia gravis muscles. Evidences for a compensatory mechanism triggered by receptor loss","volume":"102","author":"Guyon","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jneuroim.2010.10.024_bb0080","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/85520","article-title":"Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies","volume":"7","author":"Hoch","year":"2001","journal-title":"Nat Med"},{"key":"10.1016\/j.jneuroim.2010.10.024_bb0085","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S0003-4975(00)01595-2","article-title":"Myasthenia gravis: recommendations for clinical research standards. Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America","volume":"70","author":"Jaretzki","year":"2000","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.jneuroim.2010.10.024_bb0090","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/373158a0","article-title":"Neuregulins are concentrated at nerve-muscle synapses and activate ACh-receptor gene expression","volume":"373","author":"Jo","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.jneuroim.2010.10.024_bb0095","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1126\/science.6297000","article-title":"Monoclonal antibody to acetylcholine receptor: cell line established from thymus of patient with Myasthenia gravis","volume":"215","author":"Kamo","year":"1982","journal-title":"Science"},{"key":"10.1016\/j.jneuroim.2010.10.024_bb0100","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0896-8411(91)90018-8","article-title":"Anti-acetylcholine receptor antibodies decrease after thymectomy in patients with myasthenia gravis. Clinical correlations","volume":"4","author":"Kuks","year":"1991","journal-title":"J Autoimmun"},{"key":"10.1016\/j.jneuroim.2010.10.024_bb0105","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.conb.2005.12.003","article-title":"Assembly of the postsynaptic membrane at the neuromuscular junction: paradigm lost","volume":"16","author":"Kummer","year":"2006","journal-title":"Curr Opin Neurobiol"},{"key":"10.1016\/j.jneuroim.2010.10.024_bb0110","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1212\/01.WNL.0000150587.71497.B6","article-title":"Thymus changes in anti-MuSK-positive and -negative myasthenia gravis","volume":"64","author":"Lauriola","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2010.10.024_bb0115","doi-asserted-by":"crossref","first-page":"7868","DOI":"10.4049\/jimmunol.177.11.7868","article-title":"Microarrays reveal distinct gene signatures in the thymus of seropositive and seronegative myasthenia gravis patients and the role of CC chemokine ligand 21 in thymic hyperplasia","volume":"177","author":"Le Panse","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.jneuroim.2010.10.024_bb0120","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1002\/ana.20386","article-title":"Fewer thymic changes in MuSK antibody-positive than in MuSK antibody-negative MG","volume":"57","author":"Leite","year":"2005","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jneuroim.2010.10.024_bb0125","doi-asserted-by":"crossref","first-page":"893","DOI":"10.2353\/ajpath.2007.070240","article-title":"Myasthenia gravis thymus: complement vulnerability of epithelial and myoid cells, complement attack on them, and correlations with autoantibody status","volume":"171","author":"Leite","year":"2007","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jneuroim.2010.10.024_bb0130","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1093\/brain\/awn092","article-title":"IgG1 antibodies to acetylcholine receptors in \u2018seronegative\u2019 myasthenia gravis","volume":"131","author":"Leite","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2010.10.024_bb0135","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1006\/mcne.1996.0019","article-title":"Neuregulins in development","volume":"7","author":"Lemke","year":"1996","journal-title":"Mol Cell Neurosci"},{"key":"10.1016\/j.jneuroim.2010.10.024_bb0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/clin.1996.0001","article-title":"The thymus and the pathogenesis of myasthenia gravis","volume":"78","author":"Levinson","year":"1996","journal-title":"Clin Immunol Immunopathol"},{"key":"10.1016\/j.jneuroim.2010.10.024_bb0145","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1212\/WNL.26.11.1054","article-title":"Antibody to acetylcholine receptor in myasthenia gravis. Prevalence, clinical correlates, and diagnostic value","volume":"26","author":"Lindstrom","year":"1976","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2010.10.024_bb0150","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.0105-2896.2005.00253.x","article-title":"Genetic lesions in T-cell tolerance and thresholds for autoimmunity","volume":"204","author":"Liston","year":"2005","journal-title":"Immunol Rev"},{"key":"10.1016\/j.jneuroim.2010.10.024_bb0155","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1172\/JCI113401","article-title":"Thymus in myasthenia gravis. Isolation of T-lymphocyte lines specific for the nicotinic acetylcholine receptor from thymuses of myasthenic patients","volume":"81","author":"Melms","year":"1988","journal-title":"J Clin Invest"},{"issue":"2","key":"10.1016\/j.jneuroim.2010.10.024_bb0160","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jchemneu.2009.06.005","article-title":"The expression of the Goodpasture antigen-binding protein (ceramide transporter) in adult rat brain","volume":"38","author":"Mencarelli","year":"2009","journal-title":"J Chem Neuroanat"},{"key":"10.1016\/j.jneuroim.2010.10.024_bb0165","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1159\/000212372","article-title":"Muscle-specific receptor tyrosine kinase antibody-positive and seronegative myasthenia gravis","volume":"26","author":"Muppidi","year":"2009","journal-title":"Front Neurol Neurosci"},{"key":"10.1016\/j.jneuroim.2010.10.024_bb0170","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1136\/jnnp.2006.102517","article-title":"Epidemiology of myasthenia gravis with anti-muscle specific kinase antibodies in The Netherlands","volume":"78","author":"Niks","year":"2007","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jneuroim.2010.10.024_bb0175","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/ng0397-293","article-title":"The insulin gene is transcribed in the human thymus and transcription levels correlated with allelic variation at the INS VNTR-IDDM2 susceptibility locus for type 1 diabetes","volume":"15","author":"Pugliese","year":"1997","journal-title":"Nat Genet"},{"key":"10.1016\/j.jneuroim.2010.10.024_bb0180","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1023\/B:NEUR.0000020615.79831.51","article-title":"Neuregulins: primary or secondary signals for the control of synapse-specific gene expression","volume":"32","author":"Rimer","year":"2003","journal-title":"J Neurocytol"},{"key":"10.1016\/j.jneuroim.2010.10.024_bb0185","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1634\/theoncologist.2008-0230","article-title":"The HER-2 receptor and breast cancer: ten years of targeted anti-HER-2 therapy and personalized medicine","volume":"14","author":"Ross","year":"2009","journal-title":"Oncologist"},{"key":"10.1016\/j.jneuroim.2010.10.024_bb0190","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1172\/JCI1615","article-title":"An acetylcholine receptor alpha subunit promoter confers intrathymic expression in transgenic mice. Implications for tolerance of a transgenic self-antigen and for autoreactivity in myasthenia gravis","volume":"101","author":"Salmon","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jneuroim.2010.10.024_bb0195","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1126\/science.276.5312.599","article-title":"Maintenance of acetylcholine receptor number by neuregulins at the neuromuscular junction in vivo","volume":"276","author":"Sandrock","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.jneuroim.2010.10.024_bb0200","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1146\/annurev.neuro.22.1.389","article-title":"Development of the vertebrate neuromuscular junction","volume":"22","author":"Sanes","year":"1999","journal-title":"Annu Rev Neurosci"},{"key":"10.1016\/j.jneuroim.2010.10.024_bb0205","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.4049\/jimmunol.167.4.1935","article-title":"Somatic hypermutation and selection of B cells in thymic germinal centers responding to acetylcholine receptor in myasthenia gravis","volume":"167","author":"Sims","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.jneuroim.2010.10.024_bb0210","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1126\/science.1179220","article-title":"Myasthenia gravis: passive transfer from man to mouse","volume":"190","author":"Toyka","year":"1975","journal-title":"Science"},{"key":"10.1016\/j.jneuroim.2010.10.024_bb0215","doi-asserted-by":"crossref","first-page":"8762","DOI":"10.1523\/JNEUROSCI.20-23-08762.2000","article-title":"The Agrin\/MuSK signaling pathway is spatially segregated from the neuregulin\/ErbB receptor signaling pathway at the neuromuscular junction","volume":"20","author":"Trinidad","year":"2000","journal-title":"J Neurosci"},{"key":"10.1016\/j.jneuroim.2010.10.024_bb0220","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/nri916","article-title":"Unravelling the pathogenesis of myasthenia gravis","volume":"2","author":"Vincent","year":"2002","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jneuroim.2010.10.024_bb0225","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0140-6736(78)90073-9","article-title":"In-vitro synthesis of anti-acetylcholine-receptor antibody by thymic lymphocytes in myasthenia gravis","volume":"1","author":"Vincent","year":"1978","journal-title":"Lancet"},{"key":"10.1016\/j.jneuroim.2010.10.024_bb0230","doi-asserted-by":"crossref","first-page":"3752","DOI":"10.4049\/jimmunol.157.8.3752","article-title":"Expression of acetylcholine receptor genes in human thymic epithelial cells: implications for myasthenia gravis","volume":"157","author":"Wakkach","year":"1996","journal-title":"J Immunol"},{"key":"10.1016\/j.jneuroim.2010.10.024_bb0235","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1002\/eji.1830080808","article-title":"Intrathymic pathogenesis of myasthenia gravis: transient expression of acetylcholine receptors on thymus-derived myogenic cells","volume":"8","author":"Wekerle","year":"1978","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jneuroim.2010.10.024_bb0250","doi-asserted-by":"crossref","unstructured":"Zhang, W.J., Leite, M.I., Vincent, A., Cox, A.L., 2010. Autoantibodies in \u2018seronegative\u2019 myasthenia gravis. J Neurol Neurosurg Psychiatry 81 (11), e25.","DOI":"10.1136\/jnnp.2010.226340.32"},{"key":"10.1016\/j.jneuroim.2010.10.024_bb0240","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/mus.20069","article-title":"Clinical comparison of muscle-specific tyrosine kinase (MuSK) antibody-positive and -negative myasthenic patients","volume":"30","author":"Zhou","year":"2004","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jneuroim.2010.10.024_bb0245","doi-asserted-by":"crossref","first-page":"5842","DOI":"10.1002\/j.1460-2075.1995.tb00272.x","article-title":"Neuregulin receptors, erbB3 and erbB4, are localized at neuromuscular synapses","volume":"14","author":"Zhu","year":"1995","journal-title":"EMBO J"}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572810004741?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572810004741?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:17:08Z","timestamp":1759047428000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572810004741"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3]]},"references-count":50,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2011,3]]}},"alternative-id":["S0165572810004741"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2010.10.024","relation":{},"ISSN":["0165-5728"],"issn-type":[{"type":"print","value":"0165-5728"}],"subject":[],"published":{"date-parts":[[2011,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reduced thymic expression of ErbB receptors without auto-antibodies against synaptic ErbB in myasthenia gravis","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2010.10.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}